Ignite Creation Date:
2024-05-05 @ 9:31 PM
Last Modification Date:
2024-10-26 @ 10:05 AM
Study NCT ID:
NCT00901797
Status:
UNKNOWN
Last Update Posted:
2010-02-11
First Post:
2009-05-13
Brief Title:
Arthroscopic Rotator Interval Closure in Shoulder Instability Repair
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Tel-Aviv Sourasky Medical Center
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2009-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study Title Arthroscopic rotator interval closure in shoulder instability repair - a prospective study
Objective To evaluate the effect of arthroscopic rotator interval closure ARIC on patients with recurrent shoulder dislocations undergoing arthroscopic bankart repair ABR in terms of recurrence rehabilitation and function
Hypothesis
1 Although Hyperlax patients undergoing ABR have higher incidence of recurrent shoulder dislocations than those without hyperlaxity adding ARIC will lower the recurrent dislocation rate
2 Patients with arthroscopic bankart repair ABR and ARIC are slower in gaining the range of motion ROM but within 6 months are equal to those with ABR only
Objective To evaluate the effect of arthroscopic rotator interval closure ARIC on patients with recurrent shoulder dislocations undergoing arthroscopic bankart repair ABR in terms of recurrence rehabilitation and function
Hypothesis
1 Although Hyperlax patients undergoing ABR have higher incidence of recurrent shoulder dislocations than those without hyperlaxity adding ARIC will lower the recurrent dislocation rate
2 Patients with arthroscopic bankart repair ABR and ARIC are slower in gaining the range of motion ROM but within 6 months are equal to those with ABR only
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None